Starseed joins Cannabis Standard™ for Canadians, employers, physicians

Reformulary Group has now signed three LPs to Canada’s first cannabis formulary

TORONTO, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Reformulary Group, Canada’s leading independent drug plan management company, today announced it has signed Licensed Producer (LP) Starseed Medicinal Inc. as its third provider of medical cannabis within its Cannabis Standard™ formulary.

The addition of Starseed will provide Canadians and employers that subscribe to Reformulary’s Cannabis Standard with preferred pricing options for Starseed products. It will also help Canadian employers navigate the process of covering medical cannabis in their benefit plans and support the development of a database that captures real-world, patient-reported outcomes based on established survey tools.

This agreement is the latest in a series of announcements from Reformulary Group, which now has signed partnership agreements with three preferred LPs. To date, MedReleaf, Aphria and Starseed have all signed master service agreements (MSAs) with the company.

“Starseed’s reputation as a leading premium producer of high-quality medical cannabis products expands our network of LP partnerships and cannabis products for Cannabis Standard,” said Helen Stevenson, Reformulary Group founder and CEO. “This partnership will support our commitment to providing expert guidance to employers, clinicians and medical cannabis patients.”

Cannabis Standard will provide guidelines for Canadians and physicians based on the best available evidence and expert advice. These guidelines include lines of therapy, formulation and recommended/available strains. The guidelines were developed by Reformulary Group’s medical cannabis expert committee which includes several renowned clinicians.

“As the first LP to partner with a large plan sponsor (Laborers’ International Union of North America), this agreement with Reformulary further strengthens our commitment to deliver medical cannabis as a paid benefit,” said Angelo Tsebelis, President of Starseed Medicinal Inc.

About Reformulary Group
Reformulary Group is a healthcare company, founded in Toronto in 2011. The company’s most notable innovation is its proprietary formulary – the Reformulary® – which it sells on a subscription basis to Canadian employers. For more information, visit

About Starseed Holdings  
Starseed Holdings through its wholly-owned subsidiary Starseed Medicinal Inc., is a Health Canada licensed producer of medicinal cannabis products with a unique customer-centric approach to medical cannabis. Starseed was the first licensed cannabis producers to on-board medical cannabis to a multi-employer benefit plan. For more information, visit

Media Contact:
Alex Cerelli, MAVERICK
O: 416.640.5525 x 238
M: 905-864-5530